These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2102135)

  • 1. [Clinical and hemodynamic effects of medium-term treatment with ketanserin of 2 comparative groups of obese and non-obese hypertensive patients].
    Parrinello G
    Ann Ital Med Int; 1990; 5(4 Pt 2):477-83. PubMed ID: 2102135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and hemodynamic effects of medium-term ketanserin treatment in 2 compared groups of obese and non-obese hypertensive patients].
    Licata G; Scaglione R; Parrinello G; Capuana G; Mazzola G; Lipari R; Galantino L; Castello R
    G Clin Med; 1989 Oct; 70(10):597-603. PubMed ID: 2599284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and haemodynamic effects of ketanserin in lean and obese hypertensive patients.
    Licata G; Scaglione R; Parrinello G; Capuana G; Mazzola G; Lipari R; Castello R; Galantino L
    J Int Med Res; 1990; 18(2):112-9. PubMed ID: 2340944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in obese subjects: distinct hypertensive subgroup.
    Licata G; Scaglione R; Capuana G; Parrinello G; Di Vincenzo D; Mazzola G
    J Hum Hypertens; 1990 Feb; 4(1):37-41. PubMed ID: 2345385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study].
    Crispino M
    Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of obesity and ischaemic heart disease in hypertensive subjects.
    Scaglione R; Parrinello G; Corrao S; Ganguzza A; Di Chiara T; Arnone S; Mazzola G; Matita MC; D'Aubert MD; Licata G
    Eur Rev Med Pharmacol Sci; 1997; 1(1-3):69-75. PubMed ID: 9444802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central obesity and hypertension: the role of plasma endothelin.
    Parrinello G; Scaglione R; Pinto A; Corrao S; Cecala M; Di Silvestre G; Amato P; Licata A; Licata G
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1186-91. PubMed ID: 8972889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function.
    Scaglione R; Ganguzza A; Corrao S; Parrinello G; Merlino G; Dichiara MA; Arnone S; D'Aubert MD; Licata G
    Int J Obes Relat Metab Disord; 1995 Jun; 19(6):403-9. PubMed ID: 7550525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systemic hemodynamic evaluation of indapamide.
    Gensini G; Esente P; Giambartolomei A
    Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
    Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
    Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria.
    Casagrande P; Valvo E; Bedogna V; Loschiavo C; Giorgetti P; Graziani MS; Maschio G
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):79-83. PubMed ID: 2307549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ACE inhibition on left ventricular dimensions and haemodynamics in systemic hypertension: a radionuclide and echocardiographic study.
    Haznedaroglu IC; Erdem Y; Tokgözoglu L; Caglar M; Kes S; Sayinalp NM; Yörükan S
    Cent Afr J Med; 1995 Apr; 41(4):118-23. PubMed ID: 7788682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regional hemodynamics of the forearm. Comparison between obese and non-obese hypertensive patients].
    Raison J; London G; Safar M
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():65-9. PubMed ID: 3142431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal haemodynamic studies in obesity hypertension.
    Reisin E; Messerli FG; Ventura HO; Frohlich ED
    J Hypertens; 1987 Aug; 5(4):397-400. PubMed ID: 3668243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension.
    Strano A; Novo S; Raineri A; Alaimo G; Abrignani MG; Cutietta A
    J Hypertens Suppl; 1986 Apr; 4(1):S103-6. PubMed ID: 2939208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic and metabolic effects of ketanserin in dyslipidaemic hypertensive subjects.
    Letizia C; Sellini M; Scavo D
    Int J Tissue React; 1991; 13(2):91-3. PubMed ID: 1955297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.